Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Quelltx Inc. is currently prosecuting a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio has 1 pending office action. This workload involves 1 distinct examiner and 1 distinct art unit, showing a concentrated effort in a specific regulatory or technical niche. This focus indicates that the company's current patenting activity is directed toward a specific biological or pharmaceutical invention. The involvement of 1 distinct art unit suggests that the application is being reviewed by a specialized group.
The busiest examiner for the company is CHRISTINA L TRAN, who is handling 1 busiest examiner pending action. This action represents the total pending office actions for the portfolio. Because there is 1 distinct examiner, the current prosecution landscape for Quelltx Inc. is streamlined and focused on a specific interaction. This centralized approach allows for a clear understanding of the examiner's perspective within the Biotechnology & Pharmaceuticals area. Practitioners can focus their response strategy on this 1 pending action to advance the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, CHRISTINA L | 1 | 51.6% | +48.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17934428 | THERAPEUTICS FOR HAPLOINSUFFICIENCY CONDITIONS | TRAN, CHRISTINA L | 27d |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17934428 | THERAPEUTICS FOR HAPLOINSUFFICIENCY CONDITIONS | TRAN, CHRISTINA L | 1637 | §103 | Non-Final OA | 27d | Pending | Sep 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial